The 17th International Myeloma Workshop under the auspices of the International Myeloma Society (IMS) is devoted to fostering scientific and clinical exchange on the latest breakthroughs in multiple myeloma and related plasma cell disorders. The conference will take place September 12-15, 2019 at the Hynes Convention Center in Boston MA, USA. Over 3,000 participants are expected to attend the 17th IMW that will cover the latest genomic advances, insights into immune and microenvironmental dysregulation, new drug targets and agents, immunotherapeutic approaches including Car T-cell therapies, and breaking results from early and large randomized clinical trials.

The IMW 2019 will also feature a greatly expanded program of speakers and poster presenters selected from abstract submissions. Up to 40 young investigator award recipients will be selected from submitted abstracts for travel awards, and the chance to present their work and be honored at the Opening Ceremonies at the Boston Museum of Science. A black-tie event honoring IMS award recipients and workshop attendees will be held at the world-renowned Boston Museum of Fine Arts for the Closing Ceremonies. The 17th IMW will also feature a dedicated nursing symposium covering management and treatment of multiple myeloma. Nurses and allied health professionals are invited to attend and submit abstracts. Please join us for this defining conference on myeloma and the related plasma cells disorders.

For more information on this workshop, please visit http://imw2019boston.org/.

For more information or to join the International Myeloma Society, please visit https://www.myelomasociety.org/.

To watch the video highlights, please visit https://youtu.be/jsKrXND-nkU